Liver-cancer-center

A team consisting of the most competent medical personnel nationwide under the goal of providing the examination and treatment of and research on liver cancer that are unparalleled throughout the world, the Liver Cancer Center maximizes the synergy effect by maintaining close, mutually cooperative relationships among departments that are key to the treatment of liver cancer.

Based on diverse and effective therapies, the center provides the best examination and treatment tailored to individual patients.

To avoid uniform treatment methods and to provide the optimal examination and treatment to each patient, the center operates multidisciplinary conference on cases of liver cancer together with the Division of Gastroenterology, Department of Surgery, Department of Radiology, Department of Radiation Oncology, and Department of Pathology and implements treatment tailored to individual patients.

In particular, the Liver Transplantation Team—which has accumulated experience by performing a total of over 1,000 surgeries since its successful liver transplantation in 1988, an event unprecedented in Korea—has performed living donor liver transplantation (LDLT) in cases of liver cancer, thus exhibiting excellent results in the 1-year, 3-year, and 5-year survival rates after the treatment, which amount to 94.9%, 73.7%, and 72.5%, respectively (1999-2005).

The Department of Radiology plays an important role by participating in the overall examination and treatment of liver cancer from the early diagnosis of liver cancer using liver ultrasonography, CT, and MRI to the treatment of liver cancer such as transarterial chemoembolization (TACE) and radiofrequency ablation (RFA), and the radiological treatment of complications due to liver cancer and, based on its wealth of experience and competence, exhibits 1-year survival rates of 60.6% (TACE) and 97.9% (RFA), thus boasting the highest treatment rates around the nation.

In addition, in the case of percutaneous ethanol injection therapy (PEIT), which is a representative locoregional therapy whose advantages are high effectiveness, safety, and economy and which is performed directly by the Division of Gastroenterology, after surgery, the complete tumor necrosis rate is 83%, and the 1-year, 2-year, and 3-year survival rates are 98%, 96%, and 88%, respectively, thus exhibiting results similar to those of surgical excision. 

In cases where liver cancer cannot be treated with surgery or has created blood clots (thrombi) in blood vessels and where lymph nodes have metastasized to bones or the brain, radiation therapy can be performed to increase the survival time and to improve the quality of life. Depending on the locations and ranges of the tumors and the patients’ conditions, the Department of Radiation Oncology applies diverse forms of radiation therapy including 3-dimensional conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and respiratory-gated radiation therapy.

Liver cancer conference for multidisciplinary treatment/approach
Liver cancer conference for multidisciplinary treatment/approach